medline.ch Dermatologie Psoriasis

	Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the Hisayama Score: a single-center retrospective study. Immunol Med Kobayashi A, Terui H, Shimada-Omori R, Okazaki T, Sekine M, Yano M, Takahashi T, Asano Y. PMID: 41841525 [PubMed - as supplied by publisher]
	INulin-type Î²-fructans supplementation to modulate gut microbiota and assessment of its effects on health status and GUT-SKIN axis parameters in patients with psoriasis (INGUTSKIN): the 8-week, randomised, double-blind, placebo-controlled clinical study protocol. Nutr J Krupa-Kozak U, Owczarczyk-Saczonek A, Lange E, Starowicz M, Kopcewicz M, K, Czerwi, Rybak-d'Obyrn J, Oczkowski M, De Biasi J, Bieglecka K, Kleniewska M, B, Ma, Pastuszak K. PMID: 41840402 [PubMed - as supplied by publisher]
	Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study. Exp Dermatol Okuyama R, Okubo Y, Imafuku S, Tada Y, Yamanaka K, Sugiura K, Yamaguchi Y, Yasuda M, Sakamoto W, Saitoh M, Morita A. PMID: 41840359 [PubMed - indexed for MEDLINE]
	Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis). Dermatol Ther (Heidelb) Ibba L, Di Giulio S, Malagoli P, Balato A, Marzano AV, Megna M, Orsini D, Sacchelli L, Mercuri SR, Trovato E, Giacalone S, Pedron A, Caproni M, Cammarata E, Cuccia A, Altomare A, Brunasso AMG, Dini V, Ribero S, Zerbinati N, Messina F, Caccavale S, Carrera CG, Potestio L, Lora V, Carugno A, Bardazzi F, Paolino G, Costanzo A, Narcisi A, Valenti M. PMID: 41840326 [PubMed - as supplied by publisher]
	Immunometabolic Dysregulation in Psoriasis: Mechanisms Driving Inflammation and Emerging Therapeutic Targets. Immunol Invest Jaswal A, Kumar A, Patel P, Kurmi BD. PMID: 41839448 [PubMed - as supplied by publisher]
	Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque Psoriasis. Cutis Bagel J, Hetzel A, Reed A, Nelson E. PMID: 41839022 [PubMed - indexed for MEDLINE]
	Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis. Cutis Y, Korkmaz S, Çelik HHA, Büyükbayram H, Çelik S, Orhan H, Y, Erturan . PMID: 41839009 [PubMed - indexed for MEDLINE]
	Study protocol for a feasibility randomised controlled trial of MOVE SMART-An intervention to increase physical activity, reduce sedentary behaviour and improve health outcomes in patients with psoriasis. PLoS One Onambele-Pearson G, Ives B, Khosla I, Witkam R, Roberts M, Moorhead L, Bedson E, Cowper R, Burnside G, Young HS. PMID: 41838662 [PubMed - indexed for MEDLINE]
	Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies. Rheumatology (Oxford) Gossec L, Coates LC, Landewé RBM, Mease PJ, Merola JF, Ritchlin CT, Tanaka Y, Asahina A, Proft F, Goldammer N, Manente M, Ink B, Bajracharya R, Coarse J, McInnes IB. PMID: 41838419 [PubMed - as supplied by publisher]
	Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis with Diabetes: Pooled Subgroup Analysis of reSURFACEÂ 1 and reSURFACEÂ 2. Dermatol Ther (Heidelb) Bagel J, Gogineni R, Shaikh A, Lebwohl MG. PMID: 41838287 [PubMed - as supplied by publisher]
	Reporting of the harms from randomized controlled trials for psoriasis: a cross-sectional meta-epidemiological study. Front Med (Lausanne) Yang Z, Xiong Y, Shen Y, Cheng Z, Dai Y, Hao P, Hu Z. PMID: 41836958 [PubMed]
	Machine learning-based prediction of PASI100 response to secukinumab in patients with psoriasis: a real-world study with SHAP interpretability analysis. Front Med (Lausanne) Hu F, Gong J, Li Y, Tao X, Zhang L. PMID: 41836943 [PubMed]
	Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies. Cureus Martínez Villarreal JD, Garcia-Campa M, Hernandez-Fuentes M, Cárdenas-de la Garza JA, Martorell A. PMID: 41835689 [PubMed]
	Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). Br J Dermatol Phan DB, Laws P, Smith CH, Griffiths CEM, Kirby B, Hughes O, Rogers G, Alabas OA, Lunt M, Warren RB, Yiu ZZN. PMID: 41834103 [PubMed - as supplied by publisher]
	Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with glucagon-like peptide-1 receptor agonists: A population cohort study from the TriNetX collaborative network. J Am Acad Dermatol Feng AS, Zhang J, Meydan Y, Liao W. PMID: 41833917 [PubMed - as supplied by publisher]
	Effect of TNF alpha inhibitors on atherosclerosis in psoriatic arthritis patients: A Systematic Review Protocol. Tunis Med Makhlouf Y, Boussaa H, Bettaieb H, Fazaa A, Dergaa I, Boudokhane M, Douggui MH, Bellakhal S, Ben Abdelghani K, Miladi S, Laatar A. PMID: 41832656 [PubMed - indexed for MEDLINE]
	Prevalence of interstitial lung disease in patients with psoriatic arthritis: a systematic review and meta-analysis. Clin Rheumatol Nakaphan P, Shotelersuk V, Pajareya P, Siranart N, Ifteqar S. PMID: 41832319 [PubMed - as supplied by publisher]
	The promise of biomarkers in Psoriatic Arthritis: Moving towards precision medicine. Best Pract Res Clin Rheumatol Kulyk M, De Vlam K. PMID: 41832134 [PubMed - as supplied by publisher]
	Safety and efficacy of brodalumab for the management of patients with moderate-to-severe psoriasis after 1 year of therapy and its efficacy in obese patients: a single-center real-world clinical practice study. Actas Dermosifiliogr Carmona-Olveira A, Alonso Suárez-Pérez J, Guillermo Garriga-Martina G, Herrera-Acosta E. PMID: 41831778 [PubMed - as supplied by publisher]
	PDE4 inhibition in pediatric psoriasis: analysis of the SPROUT study on apremilast. Expert Opin Pharmacother Di Lernia V, Sticchi A. PMID: 41830495 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 27610

Seite 1 von 1381

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung